Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed3

Role Distribution

Other Roles3

Activity Timeline

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Shyam Sundar, MD

Banaras Hindu University

Related
5 trials

Shared therapeutic areas:

Leishmaniasis, VisceralPost-kala-azar Dermal Leishmaniasis

Worked with same sponsors:

Access to Advanced Health Institute (AAHI)Bill and Melinda Gates Foundation
Collaborated on 1 trial
Similarity Score24%

Jaime Soto, MD

Fundacion Nacional de Dermatologia

Related
4 trials

Shared therapeutic areas:

Leishmaniasis, CutaneousLeishmaniasis, Mucocutaneous
Similarity Score15%

Alejandro Llanos-Cuentas, MD

Universidad Peruana Cayetano Heredia

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Mucocutaneous

Worked with same sponsors:

Access to Advanced Health Institute (AAHI)Bill and Melinda Gates Foundation
Collaborated on 1 trial
Similarity Score14%

Ana LT Rabello, MD PhD

Centro de Pesquisas Rene Rachou - Fiocruz - Minas Gerais

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Visceral
Similarity Score8%

Beena Varghese, Dr

Centre for Health and Population Research (ICDDR,B), Dhaka, Bangladesh

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Visceral
Similarity Score8%

Marcos López, PhD

The University of Akron

Related
2 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score8%

Patricio López-Jaramillo, MD, PhD

Cardiovascular Foundation of Colombia

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score8%

Robério D Leite, MD, PhD

Hospital São José de Doenças Infecciosas, Secretaria de Saúde do Estado do Ceará.

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Visceral
Similarity Score8%

Rick M Fairhurst, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
8 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score8%

Diwarkar Dinesh, Dr

Rajendra Memorial Research Institute of Medical Sciences

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Visceral
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00111514Phase 1StudyDirector

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis

Leishmaniasis, Mucocutaneous
Completed
NCT00121862Phase 2StudyDirector

Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite

Cutaneous Leishmaniasis
Completed
NCT00486382Phase 1StudyDirector

Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India

Post-kala-azar Dermal LeishmaniasisVisceral Leishmaniasis
Completed

All 3 trials loaded